A Study of GNC-035 in Relapsed or Refractory Non-Hodgkin 's Lymphoma and Other Hematological Malignancies

NCT06066203 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-hodgkin's Lymphoma

Interventions

DRUG: GNC-035

Sponsor

Sichuan Baili Pharmaceutical Co., Ltd.

Collaborators

[object Object]